AKT1 and idiopathic pulmonary fibrosis: Most importantly, PRRX1 knock down did not inhibit the activation of non-canonical/SMAD-independent TGF-β receptor-mediated signaling pathway such as AKT and JNK, in both control and IPF fibroblast (data not shown).